Comparison of GI levels of superfine sugar and fructose in patients with type 2 diabetes or impaired glucose tolerance
- Conditions
- Type 2 diabetes mellitus or impaired glucose tolerance
- Registration Number
- JPRN-UMIN000037949
- Lead Sponsor
- InCROM Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Not provided
(1) Present or history of hepatic disorder, renal disorder, cardiovascular disease, respiratory disease, endocrine system disease, metabolic disease, neurological disease, or psychiatric disease which is not relevant for enrollment in the study as determined by the principal investigator or sub-investigator during the pre-study examinations (2) Present or history of serious allergy or hypersensitivity (3) Known allergic symptoms or aggravation of such symptoms when consuming sugar or a similar product (4) Present or history of drug or alcohol dependence (5) Medical treatment for diabetes with: a) insulin b) GLP-1 receptor agonist, or c) thiazolidine compound (6) Medical treatment for diabetes with 2 or more medications (7) Blood glucose level exceeding 200 mg/dL by self-measured glucometer before ingest of the reference diet (8) Other subjects who are not eligible for the study as determined by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GI levels of superfine sugar and fructose computed when glucose solution 50 g/150 mL is ingested as the reference diet
- Secondary Outcome Measures
Name Time Method